Market Overview:
The global cancer supportive care products market is expected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing incidence of cancer, rising awareness about cancer supportive care products, and technological advancements in the field of oncology. Based on type, the global cancer supportive care products market is segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infective agents, anti-emetics, monoclonal antibodies (mAbs), erythropoietin stimulating agents (ESAs), opioid analgesics, bisphosphonates and others. NSAIDs are expected to dominate the market in terms of revenue share during the forecast period owing to their high usage rates for pain relief among patients with various types of cancers. Based on application, lung cancer is estimated to account for a major share of the global cancer supportive care products market in 2018 owing to its high prevalence across all regions globally.
Product Definition:
Cancer supportive care products are used to improve the quality of life for cancer patients. They may include products such as wigs, hats, bras, and other clothing items that help conceal the effects of cancer or its treatment. They may also include items such as lotions and skin care products that can help relieve dryness or itching caused by chemotherapy or radiation therapy.
Nonsteroidal Anti-inflammatory Drugs:
Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to reduce the inflammation associated with cancer. They act as a cyclooxygenase inhibitor and therefore, reduces the production of prostaglandins which causes less pain, reduced fever and increased appetite. NSAIDs are not used for treatment or prevention of COVID-related conditions such as cardiovascular diseases, renal failure or gastrointestinal disorders.
Anti-infective:
Anti-infective is a category of drugs that are used to treat or prevent disease caused by microorganisms such as bacteria, viruses, and fungi. Anti-infectives can be used in cancer supportive care products to reduce the duration and severity of infectious diseases.
Application Insights:
The lung cancer segment dominated the market in 2017 owing to the increasing prevalence of the disease. According to data published by WHO, in 2018, around 210,000 new cases were reported globally every year and around 90% of these cases are found in Asia Pacific and Europe. In addition, due to rising awareness among people about early detection methods and availability of treatment options such as chemotherapy and radiation therapy for advanced stage patients, revenue generated by this segment is expected to grow at a lucrative rate during the forecast period.
Breast cancer supportive care products are gaining significant popularity due to increasing incidence rates coupled with advances made in treatment procedures over recent years. Breast Cancer Awareness Month was first observed back in October 2016 when it was launched as an annual event by Susan G Komen Foundation; since then many similar initiatives have been taken up across various parts of world including India where pinkwashing has become a trend several years ago which supports growth witnessed for this application segment over recent times.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of supportive care service providers, increasing awareness about advanced treatments, and availability of highly skilled oncologists & hematologists. Moreover, favorable reimbursement policies are also expected to drive growth during the forecast period. Asia Pacific is estimated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and rising patient disposable income levels coupled with high unmet medical needs pertaining cancer care in this region.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the global cancer supportive care products market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and around 600,920 people will die from this disease. This high incidence rate of cancer is expected to drive demand for various types of cancer supportive care products such as chemotherapy drugs and radiation therapy equipment over the forecast period.
- Rising awareness about available treatments: The growing awareness about available treatments for different types of cancers is another key factor driving demand forcancer supportive care products market globally . There has been a rise in public awareness programs and campaigns conducted by various government and non-government organizations to spread information about early detection and treatment options for different typesof cancers . This is expected to boost demandforcancer supportive care products overthe forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Cancer Supportive Care Products Market Research Report
By Type
Nonsteroidal Anti-inflammatory Drugs, Anti-infective, Anti-emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Others
By Application
Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukaemia, Ovarian Cancer, Melanoma, Others
By Companies
Novartis, Johnson & Johnson, Hoffmann LA- Roche, Amgen, Baxter, APR Applied Pharma Science Research, Fagron, Teva Pharmaceuticals Industries, Kyowa Hakko Kirin, Acacia Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Cancer Supportive Care Products Market Report Segments:
The global Cancer Supportive Care Products market is segmented on the basis of:
Types
Nonsteroidal Anti-inflammatory Drugs, Anti-infective, Anti-emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukaemia, Ovarian Cancer, Melanoma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Johnson & Johnson
- Hoffmann LA- Roche
- Amgen
- Baxter
- APR Applied Pharma Science Research
- Fagron
- Teva Pharmaceuticals Industries
- Kyowa Hakko Kirin
- Acacia Pharma
Highlights of The Cancer Supportive Care Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nonsteroidal Anti-inflammatory Drugs
- Anti-infective
- Anti-emetics
- Monoclonal Antibodies
- Erythropoietin Stimulating Agents
- Opioid Analgesics
- Bisphosphonates
- Others
- By Application:
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Bladder Cancer
- Leukaemia
- Ovarian Cancer
- Melanoma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cancer Supportive Care Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cancer supportive care products are those that help to improve the quality of life for people with cancer. They can include things like pain relief medication, emotional support, and physical therapy.
Some of the major companies in the cancer supportive care products market are Novartis, Johnson & Johnson, Hoffmann LA- Roche, Amgen, Baxter, APR Applied Pharma Science Research, Fagron, Teva Pharmaceuticals Industries, Kyowa Hakko Kirin, Acacia Pharma.
The cancer supportive care products market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cancer Supportive Care Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cancer Supportive Care Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cancer Supportive Care Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cancer Supportive Care Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cancer Supportive Care Products Market Size & Forecast, 2020-2028
4.5.1 Cancer Supportive Care Products Market Size and Y-o-Y Growth
4.5.2 Cancer Supportive Care Products Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Nonsteroidal Anti-inflammatory Drugs
5.2.2 Anti-infective
5.2.3 Anti-emetics
5.2.4 Monoclonal Antibodies
5.2.5 Erythropoietin Stimulating Agents
5.2.6 Opioid Analgesics
5.2.7 Bisphosphonates
5.2.8 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Lung Cancer
6.2.2 Breast Cancer
6.2.3 Prostate Cancer
6.2.4 Liver Cancer
6.2.5 Bladder Cancer
6.2.6 Leukaemia
6.2.7 Ovarian Cancer
6.2.8 Melanoma
6.2.9 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cancer Supportive Care Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cancer Supportive Care Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Nonsteroidal Anti-inflammatory Drugs
9.6.2 Anti-infective
9.6.3 Anti-emetics
9.6.4 Monoclonal Antibodies
9.6.5 Erythropoietin Stimulating Agents
9.6.6 Opioid Analgesics
9.6.7 Bisphosphonates
9.6.8 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Lung Cancer
9.10.2 Breast Cancer
9.10.3 Prostate Cancer
9.10.4 Liver Cancer
9.10.5 Bladder Cancer
9.10.6 Leukaemia
9.10.7 Ovarian Cancer
9.10.8 Melanoma
9.10.9 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Nonsteroidal Anti-inflammatory Drugs
10.6.2 Anti-infective
10.6.3 Anti-emetics
10.6.4 Monoclonal Antibodies
10.6.5 Erythropoietin Stimulating Agents
10.6.6 Opioid Analgesics
10.6.7 Bisphosphonates
10.6.8 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Lung Cancer
10.10.2 Breast Cancer
10.10.3 Prostate Cancer
10.10.4 Liver Cancer
10.10.5 Bladder Cancer
10.10.6 Leukaemia
10.10.7 Ovarian Cancer
10.10.8 Melanoma
10.10.9 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Nonsteroidal Anti-inflammatory Drugs
11.6.2 Anti-infective
11.6.3 Anti-emetics
11.6.4 Monoclonal Antibodies
11.6.5 Erythropoietin Stimulating Agents
11.6.6 Opioid Analgesics
11.6.7 Bisphosphonates
11.6.8 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Lung Cancer
11.10.2 Breast Cancer
11.10.3 Prostate Cancer
11.10.4 Liver Cancer
11.10.5 Bladder Cancer
11.10.6 Leukaemia
11.10.7 Ovarian Cancer
11.10.8 Melanoma
11.10.9 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Nonsteroidal Anti-inflammatory Drugs
12.6.2 Anti-infective
12.6.3 Anti-emetics
12.6.4 Monoclonal Antibodies
12.6.5 Erythropoietin Stimulating Agents
12.6.6 Opioid Analgesics
12.6.7 Bisphosphonates
12.6.8 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Lung Cancer
12.10.2 Breast Cancer
12.10.3 Prostate Cancer
12.10.4 Liver Cancer
12.10.5 Bladder Cancer
12.10.6 Leukaemia
12.10.7 Ovarian Cancer
12.10.8 Melanoma
12.10.9 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Nonsteroidal Anti-inflammatory Drugs
13.6.2 Anti-infective
13.6.3 Anti-emetics
13.6.4 Monoclonal Antibodies
13.6.5 Erythropoietin Stimulating Agents
13.6.6 Opioid Analgesics
13.6.7 Bisphosphonates
13.6.8 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Lung Cancer
13.10.2 Breast Cancer
13.10.3 Prostate Cancer
13.10.4 Liver Cancer
13.10.5 Bladder Cancer
13.10.6 Leukaemia
13.10.7 Ovarian Cancer
13.10.8 Melanoma
13.10.9 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cancer Supportive Care Products Market: Competitive Dashboard
14.2 Global Cancer Supportive Care Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Johnson & Johnson
14.3.3 Hoffmann LA- Roche
14.3.4 Amgen
14.3.5 Baxter
14.3.6 APR Applied Pharma Science Research
14.3.7 Fagron
14.3.8 Teva Pharmaceuticals Industries
14.3.9 Kyowa Hakko Kirin
14.3.10 Acacia Pharma
